Fundamental Analysis Stories

HBAN
  over six months ago at Macroaxis 
By Vlad Skutelnik
Huntington Bancshares Enterprise Value over EBIT is quite stable at the moment as compared to the past year. The company's current value of Enterprise Value over EBIT is estimated at 19.24. Price to Earnings Ratio is expected to rise to 11.84 this year, although the value of Net Income Per Employee will most likely fall to about 67.6 K. Huntington Bancshares is scheduled to announce its earnings today. The next earnings report is expected on the 22nd of April 2021. Is financial services space attracting new institutional investors, let's check if Huntington Bancshares Incorpora is sending any bullish signals. We will evaluate if Huntington Bancshares shares are reasonably priced going into February. Huntington Bancshares current probability of distress is under 40 percent. Will institutional investors continue to be optimistic, or should we expect a sell-off?
CTXS
  over six months ago at Macroaxis 
By Ellen Johnson
Citrix Systems Long Term Debt to Equity is relatively stable at the moment as compared to the past year. Citrix Systems reported last year Long Term Debt to Equity of 0.80. As of 01/21/2021, Receivables Turnover is likely to grow to 5.29, while Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop slightly above 842.3 M. Even with relatively invariable forward indicators, Citrix Systems is not utilizing all of its potentials. The current stock price agitation, may contribute to a short-term swings for the retail investors. We currently estimate Citrix Systems as undervalued. The real value is approaching 132.86 per share.
FULT
  over six months ago at Macroaxis 
By Raphi Shpitalnik
Fulton Financial Free Cash Flow per Share is comparatively stable at the moment as compared to the past year. Fulton Financial reported Free Cash Flow per Share of 0.52 in 2020. Price to Book Value is likely to gain to 1.43 in 2021, whereas Average Assets are likely to drop slightly above 23.5 B in 2021. Fulton Financial is scheduled to announce its earnings today. The next earnings report is expected on the 20th of April 2021. As many risky investors are excited about financial services space, it is only fair to review Fulton Financial based on its current volatility. We will analyze why it could be a much better year for Fulton Financial shareholders. Will private investors continue to hold, or should we expect a sell-off?
NCBS
  over six months ago at Macroaxis 
By Ellen Johnson
Nicolet Bankshares Revenue to Assets are relatively stable at the moment as compared to the past year. Nicolet Bankshares reported last year Revenue to Assets of 0.06. As of 01/17/2021, Debt to Equity Ratio is likely to grow to 6.31, while Average Assets are likely to drop slightly above 3.1 B. Even with relatively invariable essential indicators, Nicolet Bankshares is not utilizing all of its potentials. The current stock price agitation, may contribute to a short-term swings for the retail investors. Will retail investors continue to hold, or should we expect a sell-off?
YTEN
  over six months ago at Macroaxis 
By Ellen Johnson
Despite quite sluggish fundamental indicators, Yield10 Bioscience may actually be approaching a critical reversion point that can send shares even higher in February 2021. Will institutional investors continue to hold, or should we expect a sell-off?
DBVT
  over six months ago at Macroaxis 
By Raphi Shpitalnik
In spite of comparatively fragile basic indicators, DBV Technologies unveiled solid returns over the last few months and may actually be approaching a breakup point. The company current probability of distress is under 3 percent. Will private investors continue to be optimistic, or should we expect a sell-off?
AT
  over six months ago at Macroaxis 
By Achuva Shats
Atlantic Power Working Capital is comparatively stable at the moment as compared to the past year. Atlantic Power reported Working Capital of 26.82 Million in 2020. Current Ratio is likely to gain to 1.19 in 2021, whereas Asset Turnover is likely to drop 0.28 in 2021. The upcoming quarterly report is expected on the 25th of February 2021. The stock is currently undergoing an active upward rally. While some of us are getting worried about utilities space, it is reasonable to review Atlantic Power using its current fundamental data. We will analyze why Atlantic Power investors may still consider a stake in the business. The entity current odds of distress is under 48 percent. Will private investors continue to be optimistic, or should we expect a sell-off?
C
  over six months ago at Macroaxis 
By Achuva Shats
Citigroup Net Income Per Employee is projected to increase significantly based on the last few years of reporting. The past year's Net Income Per Employee was at 87,304.5. The current year Average Equity is expected to grow to about 233.9 B, whereas Revenue Per Employee is forecasted to decline to about 416.8 K. If you have been following Citigroup you may be considering taking in. Let's check if strong technical and fundamental indicators will continue to push the price to rise for Citigroup's investors. We currently estimate Citigroup as undervalued. The real value is approaching 73.83 per share.
PNC
  over six months ago at Macroaxis 
By Vlad Skutelnik
PNC Financial Average Assets are projected to increase significantly based on the last few years of reporting. The past year's Average Assets were at 328.06 Billion. The current year Average Equity is expected to grow to about 44.2 B, whereas Net Income Per Employee is forecasted to decline to about 82.3 K. Despite somewhat strong technical and fundamental indicators, PNC Financial is not utilizing all of its potentials. The latest stock price disturbance, may contribute to a short-term swings for the investors. Will investors continue to hold, or should we expect a sell-off?
ORGO
  over six months ago at Macroaxis 
By Raphi Shpitalnik
Despite quite weak basic indicators, Organogenesis Holdings may actually be approaching a critical reversion point that can send shares even higher in February 2021. The company actively responds to the market. We can now inspect Organogenesis as a potential investment option for your portfolios.